Globus Medical (GMED) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.34
- Estimate
- $1.10
- Surprise
- +21.9%
- Revenue (period 2026-06-30)
- $789.6M
- Score at report (before → after)
- 7.6 → 7.4/10
Revenue source: xbrl.
How the report landed
Globus Medical (GMED) beat the $1.10 estimate with adjusted EPS of $1.34 — a large 21.9% upside surprise. TrendMatrix's engine moved from Buy (Wait) (7.6/10) to Hold at 7.4/10 after the report — the engine's score fell despite the beat.
Where TrendMatrix's rating stands now
TrendMatrix currently rates GMED Hold at 6.7/10.
4 of the last 4 quarters beat the estimate; this quarter's +21.9% surprise compares with a +26.4% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- V7 quality resilience bonus: +0.2 (Q=7.4 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Analyst target reached - limited upside remaining
- Earnings in 1 day - binary event risk
- Target reached (0.8% upside)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $87.10
- Price target
- $87.80
- Stop
- $81.44
- Upside to target
- +0.8%
- Reward-to-risk
- 0.1:1
The stock trades at 20.4× trailing but 14.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 1.8× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-04 — shown for context, not personalized investment advice.
GMED at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $10.68B
- P/E (fwd)
- 14.8
- P/E (ttm)
- 20.4
- 52-week range
- $60.26–$101.40
- Off 52-week high
- 14.1%
- RSI (14)
- 65
- Volume vs avg
- 1.80×
- Score today
- 6.7/10